Nanomedicine
Taylor and Francis Ltd.
United Kingdom
journal
SJR by Edition
Subject Categories
- DevelopmentQ1
- BioengineeringQ2
- Biomedical EngineeringQ2
- Materials Science (miscellaneous)Q2
- Medicine (miscellaneous)Q2
- Nanoscience and NanotechnologyQ2
Areas: Chemical Engineering · Engineering · Materials Science · Medicine · Social Sciences
Most published research topics
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
1748-6963, 1743-5889
SJR Best Quartile
Q1
Region
Western Europe
Citations per Document (2 years)
3.96
References per Document
79.79
Coverage
2006-2026
Scope
Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond. As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches. Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community.
Metrics from SCImago Journal Rank 2025. View on SCImago